(S)-2-(1-Hydroxy-4-methylpent-2-ylamino)-6-[4-(5-pyrimidinyl)phenylamino]-9-iso-propylpurine

ID: ALA2295956

PubChem CID: 76320343

Max Phase: Preclinical

Molecular Formula: C24H30N8O

Molecular Weight: 446.56

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)CC[C@H](O)Nc1nc(Nc2ccc(-c3cncnc3)cc2)c2ncn(C(C)C)c2n1

Standard InChI:  InChI=1S/C24H30N8O/c1-15(2)5-10-20(33)29-24-30-22(21-23(31-24)32(14-27-21)16(3)4)28-19-8-6-17(7-9-19)18-11-25-13-26-12-18/h6-9,11-16,20,33H,5,10H2,1-4H3,(H2,28,29,30,31)/t20-/m0/s1

Standard InChI Key:  ZWHTWAOLEGXRTP-FQEVSTJZSA-N

Molfile:  

     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   24.3425  -18.5283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5192  -21.8020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3445  -19.3458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4547  -17.3002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9718  -22.2117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6903  -21.7997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4578  -18.1179    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.1948  -21.3920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5203  -20.9828    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.7088  -20.7237    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.9265  -19.3470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4207  -23.4339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7092  -22.0526    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.7416  -16.8911    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.1074  -20.9842    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.4002  -22.2128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9725  -23.0284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9643  -22.8288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9311  -20.9792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2215  -19.7617    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.1068  -21.8009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9313  -21.7975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6400  -19.7597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8127  -22.2139    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.2257  -22.2148    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.7538  -18.5245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2239  -20.5784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0455  -18.1216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7631  -23.0001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9202  -18.5343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2693  -21.7986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0407  -17.3083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6300  -18.1264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 21 15  1  6
 19 22  1  0
 22 13  1  0
  5 17  1  0
  5 31  1  0
  8 10  2  0
 19 27  2  0
  7  4  2  0
 10 19  1  0
  4 14  1  0
 20 11  1  0
 14 32  2  0
 18 29  1  0
 13  8  1  0
  9  2  2  0
 27  9  1  0
 23  3  1  0
 18 12  1  0
  2 25  1  0
 21 16  1  0
  1 28  1  0
  6  5  1  0
  3  1  2  0
  1 33  1  0
 27 20  1  0
 16  6  1  0
 26  7  1  0
 32 28  1  0
 33 30  2  0
 13 18  1  0
 30 11  1  0
 25 22  2  0
 24 21  1  0
  2 24  1  0
 11 23  2  0
 28 26  2  0
M  END

Associated Targets(Human)

DYRK1A Tchem Dual-specificity tyrosine-phosphorylation regulated kinase 1A (6484 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK5 Tchem Cyclin-dependent kinase 5/CDK5 activator 1 (3697 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem Cyclin-dependent kinase 2/cyclin A (2220 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

G2/mitotic-specific cyclin-B (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3-beta Glycogen synthase kinase-3 (925 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1D Casein kinase 1, delta tv1 (43 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 446.56Molecular Weight (Monoisotopic): 446.2543AlogP: 4.77#Rotatable Bonds: 9
Polar Surface Area: 113.67Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 10.51CX Basic pKa: 3.64CX LogP: 4.07CX LogD: 4.07
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.31Np Likeness Score: -0.75

References

1. Demange L, Lozach O, Ferandin Y, Hoang NT, Meijer L, Galons H.  (2013)  Synthesis and evaluation of new potent inhibitors of CK1 and CDK5, two kinases involved in Alzheimers disease,  22  (7): [10.1007/s00044-012-0334-1]

Source